ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 8 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,382,000 | -17.4% | 3,048,297 | -50.7% | 0.01% | -16.7% |
| Q3 2019 | $22,256,000 | +27.0% | 6,182,182 | -5.4% | 0.01% | +20.0% |
| Q2 2019 | $17,522,000 | -16.9% | 6,538,225 | -8.2% | 0.01% | -16.7% |
| Q1 2019 | $21,083,000 | +146.1% | 7,122,641 | +32.2% | 0.01% | +100.0% |
| Q4 2018 | $8,568,000 | -50.2% | 5,388,801 | +15.3% | 0.00% | -25.0% |
| Q3 2018 | $17,206,000 | +18.2% | 4,675,600 | -9.1% | 0.00% | 0.0% |
| Q2 2018 | $14,558,000 | -31.1% | 5,143,943 | -9.6% | 0.00% | -20.0% |
| Q1 2018 | $21,119,000 | +140.6% | 5,692,397 | +86.8% | 0.01% | +150.0% |
| Q4 2017 | $8,778,000 | -31.1% | 3,047,814 | +7.5% | 0.00% | -33.3% |
| Q3 2017 | $12,731,000 | -24.7% | 2,835,538 | -23.0% | 0.00% | -25.0% |
| Q2 2017 | $16,906,000 | +5.9% | 3,683,294 | -2.9% | 0.00% | 0.0% |
| Q1 2017 | $15,969,000 | -14.6% | 3,793,067 | -16.3% | 0.00% | -20.0% |
| Q4 2016 | $18,707,000 | -58.6% | 4,529,542 | -18.8% | 0.01% | -61.5% |
| Q3 2016 | $45,198,000 | +44.4% | 5,580,040 | +39.1% | 0.01% | +30.0% |
| Q2 2016 | $31,290,000 | +46.5% | 4,011,635 | +45.0% | 0.01% | +42.9% |
| Q1 2016 | $21,353,000 | -54.8% | 2,765,894 | -36.9% | 0.01% | -53.3% |
| Q4 2015 | $47,268,000 | +75.5% | 4,380,748 | +12.4% | 0.02% | +66.7% |
| Q3 2015 | $26,936,000 | -26.7% | 3,898,228 | -6.0% | 0.01% | -18.2% |
| Q2 2015 | $36,753,000 | -9.8% | 4,148,244 | +0.4% | 0.01% | -15.4% |
| Q1 2015 | $40,725,000 | -59.5% | 4,130,307 | -49.7% | 0.01% | -58.1% |
| Q4 2014 | $100,651,000 | +53.7% | 8,216,440 | +25.2% | 0.03% | +55.0% |
| Q3 2014 | $65,500,000 | +56.9% | 6,563,104 | +19.0% | 0.02% | +53.8% |
| Q2 2014 | $41,744,000 | +141.2% | 5,514,362 | +4.8% | 0.01% | +116.7% |
| Q1 2014 | $17,307,000 | -25.6% | 5,260,132 | -24.9% | 0.01% | -25.0% |
| Q4 2013 | $23,261,000 | +40.0% | 7,008,261 | +27.4% | 0.01% | +33.3% |
| Q3 2013 | $16,616,000 | -19.8% | 5,502,040 | +117.1% | 0.01% | -25.0% |
| Q2 2013 | $20,726,000 | +253.1% | 2,533,800 | +245.8% | 0.01% | +300.0% |
| Q4 2012 | $5,870,000 | +116.7% | 732,838 | +181.6% | 0.00% | +100.0% |
| Q3 2012 | $2,709,000 | +738.7% | 260,250 | +399.5% | 0.00% | – |
| Q2 2012 | $323,000 | +36.3% | 52,100 | +110.4% | 0.00% | – |
| Q1 2012 | $237,000 | – | 24,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |